journal cover

Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections

PloS One

Oct 8, 2011

Vito RacanelliF Dammacco

Abstract

Despite the production of neutralizing antibodies to hepatitis C virus (HCV), many patients fail to clear the virus and instead develop chronic infection and long-term complications. To understand how HCV infection perturbs the antibody repertoire and to identify molecular features of a...read more

Mentioned in this Paper

5-(6)-carboxyfluorescein diacetate succinimidyl ester
Neuro-Oncological Ventral Antigen 2
Neutralising Antibodies Analysis
Pathogenic Aspects
IGHV1-69 gene
T-Lymphocyte
Remission, Spontaneous
Pathogenesis
Antibodies, Viral
Immunoglobulin Activity
Paper Details
References
  • References43
  • Citations15
12345
  • References43
  • Citations15
12

Similar Papers Found In These Feeds

Plasmodium Falciparum

Malaria remains a major cause of morbidity and mortality in the tropics, with the parasite Plasmodium falciparum responsible for the majority of the disease burden. Discover the latest research on Plasmodium falciparum.

Leukemia, T-Cell

T-cell leukemia includes various types of lymphoid leukemia that affect T cells. Here is the latest research on T-cell leukemia.

Hematopoiesis & Alzheimer's Disease

The formation of blood cells, hematopoiesis, has been exploited for the potential use as a therapy in Alzheimer’s disease. Decreased levels of lymphocytes and proteins involved in stem cell recruitment are found in early stages of Alzheimer’s disease. Here is the latest research on hematopoiesis and Alzheimer’s disease.

Malaria

Malaria is a mosquito-borne infectious disease that affects humans and other animals. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. Discover the latest research on malaria here,

Neutralizing HIV Antibodies

Several methods have been utilized to isolate and characterize individual antibodies from the human repertoire and each of these methods has been applied to the generation of broadly neutralizing HIV antibodies. Discover the latest research on neutralizing HIV antibodies.

Immunoglobulin Class Switching

Immunoglobulin class switching from igm to igg and iga is central to immunity against viruses and requires the activation of b cells by t cells via cd154 and cytokines. Discover the latest research on immunoglobulin class switching here.

Neutralizing Antibodies

Neutralizing antibodies bind to their target an impair the biological activity of the target, rather than simply flagging the target for host leukocytes. This is an approach that is being used in vaccine development. Find the latest research on neutralizing antibodies here.

Hepatitis C

Hepatitis C virus causes acute and chronic liver disease in humans, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Discover the latest research on Hepatitis C here.

T cells: Costimulatory Receptors

T cell activation requires engagement of both the T cell receptor and a co-stimulatory molecule. Lack of a co-stimulatory signal can result in T cell anergy, deletion, or immune tolerance. Find the latest research on T cell co-stimulatory receptors here.

T cell Differentiation

Differentiation of naive T cells into effector cells ensures optimal protection against pathogens and the development of immunological memory. Here is the latest research.

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

Related Papers

Journal of Clinical Pathology

Hepatitis C virus and lymphoma

Journal of Clinical PathologyNovember 29, 2007
D S Viswanatha, A Dogan
© 2020 Meta ULC. All rights reserved

Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections

PloS One

Oct 8, 2011

Vito RacanelliF Dammacco

PMID: 21980500

DOI: 10.1371/journal.pone.0025606

Abstract

Despite the production of neutralizing antibodies to hepatitis C virus (HCV), many patients fail to clear the virus and instead develop chronic infection and long-term complications. To understand how HCV infection perturbs the antibody repertoire and to identify molecular features of a...read more

Mentioned in this Paper

5-(6)-carboxyfluorescein diacetate succinimidyl ester
Neuro-Oncological Ventral Antigen 2
Neutralising Antibodies Analysis
Pathogenic Aspects
IGHV1-69 gene
T-Lymphocyte
Remission, Spontaneous
Pathogenesis
Antibodies, Viral
Immunoglobulin Activity

Similar Papers Found In These Feeds

Plasmodium Falciparum

Malaria remains a major cause of morbidity and mortality in the tropics, with the parasite Plasmodium falciparum responsible for the majority of the disease burden. Discover the latest research on Plasmodium falciparum.

Leukemia, T-Cell

T-cell leukemia includes various types of lymphoid leukemia that affect T cells. Here is the latest research on T-cell leukemia.

Related Papers

Journal of Clinical Pathology

Hepatitis C virus and lymphoma

Journal of Clinical PathologyNovember 29, 2007
D S Viswanatha, A Dogan
Paper Details
References
  • References43
  • Citations15
12345
  • References43
  • Citations15
12
/papers/antibody-vh-repertoire-differences-between/21980500